Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,772 | 6,752 | 9,820 | 7,221 | 6,537 |
| Operating Income | -5,772 | -6,752 | -9,820 | -7,221 | -6,537 |
| Interest Expense | 273 | 253 | 222 | 324 | 306 |
| Other Income | 286 | -216 | 1,810 | 5,532 | -5,654 |
| Pre-tax Income | -5,759 | -7,221 | -8,232 | -2,013 | -12,497 |
| Income Tax | 8 | 4 | -3 | 11 | 4 |
| Net Income Continuous | -5,767 | -7,225 | -8,229 | -2,024 | -12,501 |
| Net Income | $-5,767 | $-7,225 | $-8,229 | $-2,024 | $-12,501 |
| EPS Basic Total Ops | -16.75 | -24.37 | 69.87 | -16.93 | -170.95 |
| EPS Basic Continuous Ops | -12.99 | -24.40 | 69.51 | -16.98 | -170.92 |
| EPS Diluted Total Ops | -16.75 | -24.37 | 69.87 | -16.93 | -170.95 |
| EPS Diluted Continuous Ops | -12.99 | -24.40 | 69.51 | -16.98 | -170.92 |
| EPS Diluted Before Non-Recurring Items | -16.81 | -24.01 | N/A | N/A | N/A |
| EBITDA(a) | $-5,378 | $-6,362 | $-9,735 | $-6,675 | $-5,864 |